𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of dacarbazine, cisplatin, interferon-α and high-dose interleukin-2 in ‘poor-risk’ metastatic melanoma

✍ Scribed by T.M. Proebstle; C. Scheibenbogen; W. Sterry; U. Keilholz

Book ID
116167929
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
452 KB
Volume
32
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of high-dose cisplatin
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma
✍ Thomas A. Steffens; Dean F. Bajorin; Paul B. Chapman; David R. Lovett; Beverly V 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 831 KB

Cisplatin and dacarbazine are used widely in the treatment of metastatic melanoma. To evaluate high-dose cisplatin and dacarbazine, 32 patients with metastatic melanoma were treated with cisplatin 50 mg/m\* and dacarbazine 350 mg/m2 daily for three days repeated at 28-day intervals. Their median age